New study digs deeper into TURALIO's liver risks for TGCT patients
NCT ID NCT04635111
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 29 times
Summary
This study looks at the long-term risk of severe liver damage in people with a type of tumor called TGCT who have taken the drug TURALIO (pexidartinib) and already had liver test problems. Researchers will track about 30 adults to see how often liver failure occurs after stopping the drug. The goal is to better understand how TURALIO can harm the liver, using optional liver biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TENOSYNOVIAL GIANT CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
-
Kamalesh K Sankhala MD INC
RECRUITINGSanta Monica, California, 90403, United States
Contact
-
Kelsey Seybold Clinic - Pearland
NOT_YET_RECRUITINGHouston, Texas, 77014, United States
Contact
-
Montefiore Medical Center
WITHDRAWNNew York, New York, 10467, United States
-
OSU - James Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
Contact
-
Sarcoma Oncology Research Center LLC
NOT_YET_RECRUITINGSanta Monica, California, 90403, United States
Contact
-
The Oncology Institute of Hope and Innovation
WITHDRAWNWhittier, California, 90602, United States
-
UCLA Hematology and Oncology
RECRUITINGSanta Monica, California, 90404, United States
Contact
Conditions
Explore the condition pages connected to this study.